Blueprints for ATP machinery will aid tuberculosis drug design

-


Nature, Published online: 03 July 2024; doi:10.1038/d41586-024-02094-1

Structural insights into how anti-tuberculosis drugs interact with the enzyme that makes ATP in bacteria and humans pave the way for improved drug design to treat the disease and combat antimicrobial resistance.



Source link

Latest news

Artemis II Mission Launches Successfully

At 6:36 pm Cape Canaveral time, NASA’s SLS rocket lifted off without incident with the four members of...

How procrastination can rob you of career fulfilment in science

Holly Newson 00:00 Welcome to Working Scientist, a Nature Careers podcast. I’m Holly Newson, and in this series,...

California Suspends Enforcement of Law Requiring VCs to Report Diversity Data

Under a new state regulation, venture capital firms operating in California were supposed to submit demographic data about...

Samsung’s Best OLED From Last Year Is Priced as Low as I’ve Seen It on Amazon

Samsung’s S95F QD-OLED is one of the best TVs we've ever tested. Its potent display provides brilliant brightness,...

FDA Approves Eli Lilly’s GLP-1 Pill

The US Food and Drug Administration on Wednesday approved a new obesity pill called Foundayo. Taken once daily,...

AI Models Lie, Cheat, and Steal to Protect Other Models From Being Deleted

In a recent experiment, researchers at UC Berkeley and UC Santa Cruz asked Google’s artificial intelligence model Gemini...

Must read

You might also likeRELATED
Recommended to you